275 related articles for article (PubMed ID: 16894855)
41. Reducing the number of drug plans for seniors: a proposal and analysis of three case studies.
Rice T; Cummings J
J Health Polit Policy Law; 2010 Dec; 35(6):961-97. PubMed ID: 21451159
[TBL] [Abstract][Full Text] [Related]
42. Medicare program; revisions to the Medicare Advantage and prescription drug benefit programs: clarification of compensation plans. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2008 Nov; 73(221):67406-14. PubMed ID: 19137670
[TBL] [Abstract][Full Text] [Related]
43. Strategies for developing a successful Medicare part D formulary.
Stefanacci RG
Manag Care; 2005 May; 14(5 Suppl):3-10. PubMed ID: 15962831
[No Abstract] [Full Text] [Related]
44. Medicare Part D: how do vulnerable beneficiaries fare?
Summer L; Nemore P; Finberg J
Issue Brief (Commonw Fund); 2008 Apr; 35():1-11. PubMed ID: 18536146
[TBL] [Abstract][Full Text] [Related]
45. Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2009 Jan; 74(11):2881-8. PubMed ID: 19385109
[TBL] [Abstract][Full Text] [Related]
46. Does greater Medicare HMO enrollment cause adverse selection into Medigap?
Desmond KA; Rice T; Fox PD
Health Econ Policy Law; 2006 Jan; 1(Pt 1):3-21. PubMed ID: 18634700
[TBL] [Abstract][Full Text] [Related]
47. HMOs in the Medicare market. Part 1.
Langwell KM; Rossiter LF; Hadley JP; Nelson SL; Nelson LM; Berman KA
Med Group Manage; 1986; 33(6):32-7, 44-5. PubMed ID: 10301140
[TBL] [Abstract][Full Text] [Related]
48. Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.
Pomey MP; Forest PG; Palley HA; Martin E
Milbank Q; 2007 Sep; 85(3):469-98. PubMed ID: 17718665
[TBL] [Abstract][Full Text] [Related]
49. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions. Final rule with comment period.
Fed Regist; 2009 Jan; 74(7):1493-549. PubMed ID: 19143114
[TBL] [Abstract][Full Text] [Related]
50. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.
Neuman P; Strollo MK; Guterman S; Rogers WH; Li A; Rodday AM; Safran DG
Health Aff (Millwood); 2007; 26(5):w630-43. PubMed ID: 17711865
[TBL] [Abstract][Full Text] [Related]
51. Managed Medicare may help seniors avoid preventable hospitalizations through better coordination of care.
Capitation Rates Data; 2008 Jul; 13(7):11-2. PubMed ID: 18649796
[No Abstract] [Full Text] [Related]
52. Alternative strategies for Medicare payment of outpatient prescription drugs--Part B and beyond.
Danzon PM; Wilensky GR; Means KE
Am J Manag Care; 2005 Mar; 11(3):173-80. PubMed ID: 15786856
[TBL] [Abstract][Full Text] [Related]
53. Medicare spending on HMOs and stand-alone drug plans: what is it worth to beneficiaries?
Austin BJ
Find Brief; 2008 Nov; 11(8):1-3. PubMed ID: 19035029
[TBL] [Abstract][Full Text] [Related]
54. HMOs in the Medicare market. Part 2--Operational issues.
Langwell KM; Rossiter LF; Hadley JP; Nelson SL; Nelson LM; Berman KA
Med Group Manage; 1987; 34(1):37-44. PubMed ID: 10301309
[No Abstract] [Full Text] [Related]
55. Section 506 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003--limitation on charges for services furnished by Medicare participating inpatient hospitals to individuals eligible for care purchased by Indian health programs. Final rule.
Indian Health Service (IHS), Center elsewhere for Medicare & Medicaid Services (CMS), Health and Human Services (HHS)
Fed Regist; 2007 Jun; 72(106):30706-11. PubMed ID: 17577967
[TBL] [Abstract][Full Text] [Related]
56. Medicare Part D: practical practice information for healthcare providers.
Moczygemba LR
J Am Acad Nurse Pract; 2006 Oct; 18(10):457-62. PubMed ID: 16999710
[TBL] [Abstract][Full Text] [Related]
57. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
[TBL] [Abstract][Full Text] [Related]
58. Stats & facts. Medicare and pharmaceutical coverage.
Manag Care Interface; 1999 Apr; 12(4):68-9. PubMed ID: 10387395
[No Abstract] [Full Text] [Related]
59. Navigating Medicare drug coverage: Part B vs. Part D.
Piper KB
Manag Care; 2006 Jul; 15(7 Suppl 3):17-20. PubMed ID: 16898056
[TBL] [Abstract][Full Text] [Related]
60. Medicare retiree drug subsidy compliance considerations.
Pudlowski E
Benefits Q; 2007; 23(1):21-7. PubMed ID: 17444082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
